OmniFusion™ RNA Lung Cancer Panel

OmniFusion™ RNA Lung Cancer Panel

For Research Use Only. Not for use in diagnostic procedures.

Known and novel fusion detection and research via amplicon-based target enrichment for Next Generation Sequencing (NGS) on Illumina sequencing platforms

  • OmniFusion™ RNA Lung Cancer Panel uses single primer amplification method to enables detection more than 530 known and unknown fusions associated with non-small cell lung cancer.

  • Fusion genes include 11 cancer driver genes ( ALK, CIT, MBIP, MET, NRG1, NTRK1, NTRK3, PDGFRA, RET, ROS1, TACC3). OmniFusion workflow allows detection of novel fusion partners and and splicing variants.

  • Compared to other methods such as qPCR, FISH, or Sanger sequencing, Paragon Genomics targeted fusion sequencing method allows robust multiplexed detection of variants using minimum sample input and a simple workflow.

Fast and reliable assay for detecting known and novel gene fusions

Sensitive Detection

Can detect down to 1% variant frequency with high confidence.

Excellent performance with extremely low rRNA rate

Prepare high-quality targeted NGS libraries using OmniFusion RNA Fusion Detection Technology to achieve minimal rRNA and over 90% on-target rate.

Fast, streamlined workflow

Generate sequencing-ready libraries in just 6.5 hours using a rapid, five-step protocol from Extracted RNA to sequence ready libraries.

Identification of known and novel RNA fusions associated with lung cancer

Interrogate >530 known RNA fusions and additional novel RNA fusions using a single-primer method. Fusion genes include 11 cancer driver genes ( ALK, CIT, MBIP, MET, NRG1, NTRK1, NTRK3, PDGFRA, RET, ROS1, TACC3).

Specifications

SKU

Description

Pack Size

SKU
Description
Pack Size

917100

OmniFusionTM RNA Lung Cancer Panel

8 reactions

SKU
Description
Pack Size

917101

OmniFusionTM RNA Lung Cancer Panel

96 reaction

SKU
Description
Pack Size

917102

OmniFusionTM RNA Lung Cancer Panel

384 reaction

SKU
Description
Pack Size

716006

CleanPlex® Dual-Indexed PCR Primers for Illumina® Set A

96 indexes, 96 reactions

RNA Lung Cancer Panel
arrow&v
arrow&v

Your content has been submitted

© 2021 Bioinnovations | Connecting Technologies to Life

Designed by Maveristic

Address

G1-G2, A-Wing, Hamirmal Tower, Station Rd, Bhayandar, Narayan Nagar, Bhayandar West, Mumbai, Maharashtra 401101, India

Quick Links